Crossref journal-article
Rockefeller University Press
Journal of Experimental Medicine (291)
Abstract

The accumulation of misfolded proteins is a fundamental pathogenic process in neurodegenerative diseases. However, the factors that trigger aggregation of α-Synuclein (α-Syn), the principal component of the intraneuronal inclusions known as Lewy bodies (LBs), and Lewy neurites (LNs), which characterize Parkinson’s disease (PD) and dementia with LBs (DLB), are poorly understood. We show here that in young asymptomatic α-Syn transgenic (Tg) mice, intracerebral injections of brain homogenates derived from older Tg mice exhibiting α-Syn pathology accelerate both the formation of intracellular LB/LN-like inclusions and the onset of neurological symptoms in recipient animals. Pathological α-Syn propagated along major central nervous system (CNS) pathways to regions far beyond injection sites and reduced survival with a highly reproducible interval from injection to death in inoculated animals. Importantly, inoculation with α-Syn amyloid fibrils assembled from recombinant human α-Syn induced identical consequences. Furthermore, we show for the first time that synthetic α-Syn fibrils are wholly sufficient to initiate PD-like LBs/LNs and to transmit disease in vivo. Thus, our data point to a prion-like cascade in synucleinopathies whereby cell–cell transmission and propagation of misfolded α-Syn underlie the CNS spread of LBs/LNs. These findings open up new avenues for understanding the progression of PD and for developing novel therapeutics.

Bibliography

Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. Y. (2012). Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. Journal of Experimental Medicine, 209(5), 975–986.

Authors 6 University of Pennsylvania
  1. Kelvin C. Luk (first) University of Pennsylvania
  2. Victoria M. Kehm (additional) University of Pennsylvania
  3. Bin Zhang (additional) University of Pennsylvania
  4. Patrick O’Brien (additional) University of Pennsylvania
  5. John Q. Trojanowski (additional) University of Pennsylvania
  6. Virginia M.Y. Lee (additional) University of Pennsylvania
References 50 Referenced 953
  1. 10.1016/S0896-6273(00)80886-7 / Neuron. / Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system by Abeliovich (2000)
  2. 10.1016/j.neuron.2009.12.016 / Neuron. / The transcellular spread of cytosolic amyloids, prions, and prionoids by Aguzzi (2009)
  3. {'key': '2023072601014952600_bib3', 'first-page': '879', 'article-title': 'Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies', 'volume': '152', 'author': 'Baba', 'year': '1998', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies by Baba (1998)
  4. 10.1371/journal.ppat.1000421 / PLoS Pathog. / De novo generation of infectious prions in vitro produces a new disease phenotype by Barria (2009)
  5. 10.1007/s00401-010-0664-3 / Acta Neuropathol. / Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders by Beach (2010)
  6. 10.1016/0022-510X(73)90175-5 / J. Neurol. Sci. / Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations by Bernheimer (1973)
  7. 10.1016/S0197-4580(02)00065-9 / Neurobiol. Aging. / Staging of brain pathology related to sporadic Parkinson’s disease by Braak (2003)
  8. 10.1016/j.neulet.2005.11.012 / Neurosci. Lett. / Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology by Braak (2006)
  9. 10.1038/nrm2873 / Nat. Rev. Mol. Cell Biol. / Prion-like transmission of protein aggregates in neurodegenerative diseases by Brundin (2010)
  10. 10.1016/j.conb.2009.03.007 / Curr. Opin. Neurobiol. / Transneuronal circuit tracing with neurotropic viruses by Callaway (2008)
  11. 10.1038/ncb1901 / Nat. Cell Biol. / Transmission and spreading of tauopathy in transgenic mouse brain by Clavaguera (2009)
  12. 10.1016/S0166-2236(97)01213-7 / Trends Neurosci. / The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease by Clayton (1998)
  13. 10.1016/0140-6736(92)93275-R / Lancet. / Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology by Daniel (1992)
  14. 10.1111/j.1471-4159.2009.06324.x / J. Neurochem. / Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology by Danzer (2009)
  15. 10.1096/fj.10-164624 / FASEB J. / Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity by Danzer (2011)
  16. 10.1007/s00401-008-0355-5 / Acta Neuropathol. / A not entirely benign procedure: progression of Parkinson’s disease by Del Tredici (2008)
  17. 10.1073/pnas.0903691106 / Proc. Natl. Acad. Sci. USA. / Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein by Desplats (2009)
  18. 10.1016/S1474-4422(09)70238-8 / Lancet Neurol. / Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria by Dickson (2009)
  19. 10.1006/exnr.1999.7228 / Exp. Neurol. / The expression of α-, β-, and γ-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases by Duda (1999)
  20. 10.1093/jnen/59.9.830 / J. Neuropathol. Exp. Neurol. / Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy by Duda (2000)
  21. 10.1126/science.1194516 / Science. / Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis by Eisele (2010)
  22. 10.1523/JNEUROSCI.5699-09.2010 / J. Neurosci. / Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival by Emmanouilidou (2010)
  23. 10.1111/j.1749-6632.2003.tb07458.x / Ann.N.Y. Acad.Sci. / Description of Parkinson’s disease as a clinical syndrome by Fahn (2003)
  24. 10.1038/ncb841 / Nat. Cell Biol. / alpha-Synuclein is phosphorylated in synucleinopathy lesions by Fujiwara (2002)
  25. 10.1016/S0896-6273(02)00682-7 / Neuron. / Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein by Giasson (2002)
  26. 10.1172/JCI43366 / J. Clin. Invest. / α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells by Hansen (2011)
  27. 10.1074/jbc.C110.113464 / J. Biol. Chem. / Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors by Kim (2010)
  28. 10.1007/s00401-005-0027-7 / Acta Neuropathol. / Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies by Klucken (2006)
  29. 10.1038/nm1747 / Nat. Med. / Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease by Kordower (2008)
  30. 10.1016/j.biocel.2008.01.017 / Int. J. Biochem. Cell Biol. / Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein by Lee (2008)
  31. 10.1038/nm1746 / Nat. Med. / Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation by Li (2008)
  32. 10.1073/pnas.0908005106 / Proc. Natl. Acad. Sci. USA. / Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells by Luk (2009)
  33. 10.1002/mds.10258 / Mov. Disord. / Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson’s disease by MacDonald (2002)
  34. 10.1371/journal.ppat.1002419 / PLoS Pathog. / Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease by Makarava (2011)
  35. 10.1523/JNEUROSCI.4308-05.2006 / J. Neurosci. / Parkinson’s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death by Martin (2006)
  36. 10.1126/science.1131864 / Science. / Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host by Meyer-Luehmann (2006)
  37. 10.1021/bi027363r / Biochemistry. / Role of alpha-synuclein carboxy-terminus on fibril formation in vitro by Murray (2003)
  38. 10.1002/cne.902060106 / J. Comp. Neurol. / The medial forebrain bundle of the rat. I. General introduction by Nieuwenhuys (1982)
  39. 10.1016/j.cell.2011.10.011 / Cell. / The seeds of neurodegeneration: prion-like spreading in ALS by Polymenidou (2011)
  40. 10.1038/nature02072 / Nature. / Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion by Prinz (2003)
  41. 10.1016/S0002-9440(10)63633-4 / Am. J. Pathol. / Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies by Sampathu (2003)
  42. 10.1099/0022-1317-73-7-1637 / J. Gen. Virol. / Scrapie in the central nervous system: neuroanatomical spread of infection and Sinc control of pathogenesis by Scott (1992)
  43. 10.1016/S0304-3940(98)00504-7 / Neurosci. Lett. / Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies by Spillantini (1998)
  44. 10.1073/pnas.95.11.6469 / Proc. Natl. Acad. Sci. USA. / alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies by Spillantini (1998)
  45. 10.1212/WNL.0b013e3181fd613b / Neurology. / Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease by Tokuda (2010)
  46. 10.1016/j.neuron.2011.08.033 / Neuron. / Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death by Volpicelli-Daley (2011)
  47. 10.1679/aohc.52.Suppl_191 / Arch. Histol. Cytol. / Lewy bodies in the enteric nervous system in Parkinson’s disease by Wakabayashi (1989)
  48. 10.1097/NEN.0b013e3186fc995 / J. Neuropathol. Exp. Neurol. / Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein by Waxman (2008)
  49. 10.1111/j.1471-4159.2010.06592.x / J. Neurochem. / A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation by Waxman (2010)
  50. 10.1074/jbc.274.28.19509 / J. Biol. Chem. / alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson’s disease by Wood (1999)
Dates
Type When
Created 13 years, 4 months ago (April 17, 2012, 1:29 a.m.)
Deposited 2 years, 1 month ago (July 25, 2023, 9:02 p.m.)
Indexed 1 hour, 36 minutes ago (Aug. 27, 2025, 12:02 p.m.)
Issued 13 years, 4 months ago (April 16, 2012)
Published 13 years, 4 months ago (April 16, 2012)
Published Online 13 years, 4 months ago (April 16, 2012)
Published Print 13 years, 3 months ago (May 7, 2012)
Funders 0

None

@article{Luk_2012, title={Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice}, volume={209}, ISSN={0022-1007}, url={http://dx.doi.org/10.1084/jem.20112457}, DOI={10.1084/jem.20112457}, number={5}, journal={Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Luk, Kelvin C. and Kehm, Victoria M. and Zhang, Bin and O’Brien, Patrick and Trojanowski, John Q. and Lee, Virginia M.Y.}, year={2012}, month=apr, pages={975–986} }